Quantitative microscopy of human DNA topoisomerase II-α expression in transitional cell carcinoma of the bladder

Analytical and Quantitative Cytology and Histology

Volumn 26, Issue 4, 2004, Pages 181-186

  Rath Wolfson, Lea ^a,b   Hammel, Ilan ^b   Kugel, Valentina ^c   Leib, Zvi ^c   Dekel, Yoram ^c   Koren, Rumelia ^a,b  

^a HASHARON HOSPITAL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

Bladder cancer; Carcinoma; DNA topoisomerase; Morphometry; Transitional cell

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE 2ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CELL NUCLEUS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; QUANTITATIVE MICROSCOPY; STAINING; TISSUE SECTION; TRANSITIONAL CELL CARCINOMA; UROGENITAL TRACT TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, TRANSITIONAL CELL; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; MIDDLE AGED; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 4143063553     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Loening S, Narayana A, Yoder L, Slymen D, Penick G, Culp D: Analysis of bladder tumor recurrence in 178 patients. Urology 1980;16:137-141
2. Walsh PC: Campbell's Urology, eighth edition, Philadelphia, WB Saunders, 2002, p 2785
3. Baak JP, Bol MG, van Diermen B, Janssen EA, Buhr-Wildhagen SB, Mestad O, Ogreid P, Kjellevold KH. DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality. Urology 2003;61:1266-127
4. Capranuco G, Tinelli S, Austin CA, Fisher ML, Zunino F: Differential patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development. Biochim Biophys Acta 1992;1132:43-48
5. Davies SM, Robson CN, Davies SL, Hickson TD: Nuclear topoisomerase II levels correlate with the sensitivity of mammalian cells to intercalating agents and epipodophyllotoxins. J Biol Chem 1988;263:17724-17729
6. Drake FH, Hofmann GA, Bartus HF, Mattern MR, Crooke ST, Mirabelli CK: Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry 1989;28:8154-8160
7. Fry AM, Chresta CM, Davies SM: Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines. Cancer Res 1991;51:6592-6595
8. Guinee DG Jr, Holden JA, Benfield JR, Woodward ML, Przygodzki RM, Fishback NF, Koss MN, Travis WD: Comparison of DNA topoisomerase II-α expression in small cell and non small cell carcinoma of the lung: In search of a mechanism of chemotherapeutic response. Cancer 1996;78:729-735
9. Heck MM, Earnshaw WC: Topoisomerase II: A specific marker for cell proliferation. J Cell Biol 1986;103:2569-2581
10. Holden JA, Perkins SL, Snow GW, Kjeldsberg CR: Immunohistochemical staining for DNA topoisomerase II in non-Hodgkin's lymphomas. Am J Clin Pathol 1995;104:54-59
11. Monnin KA, Bronstein IB, Gaffney D, Holden JA: Elevations of DNA topoisomerase I in transitional cell carcinoma of the urinary bladder: Correlation with DNA topoisomerase II-α and p-53 expression. Hum Pathol 1999;30:384-391
12. Epstein JI, Amin MB, Reuter VR, Mostofi FK: The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435-1448
13. Frank I, Cheville JC, Blute ML, Lohse CM, Nehra A, Weaver AL, Karnes RJ, Zincke H: Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: Clinicopathologic features associated with outcome. Cancer 2003;97:2425-2431
14. Broders AC: Epithelioma of the genitourinary organs. Ann Surg 1922;75:574-575
15. Mostofi FK, Sobin LH, Torlani H: Histologic typing of urinary bladder tumors. International Histological Classification of Tumors. Geneva, World Health Organization, 1973
16. Graem N, Helweg-Larsen K, Keiding N: Precision of histological grading of malignancy. Acta Pathol Microbiol Scand [A] 1980;88:307-317
17. Ooms EC, Kurver PH, Veldhuizen RW, Alons CL, Boon ME: Morphometric grading of bladder tumors in comparison with histologic grading by pathologists. Hum Pathol 1983;14:144-150
18. Ooms EC, Anderson WA, Alons CL, Boon ME, Veldhuizen RW: Analysis of the performance of pathologists in the grading of bladder tumors. Hum Pathol 1983;14;140-143
19. Tosoni I, Wagner U, Sauter G, Egloff M, Knonagel H, Alund G, Bannwart F, Mihatsch MJ, Gasser TC, Maurer R: Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer. Br J Urol Int 2000;85:48-53
20. Sabo E, Gibrat M, Sova Y, Stein A, Resnick MB: Validation of the novel indices of nuclear pleomorphism, polarity and spatial distribution in the grading of urothelial carcinoma. Analyt Quant Cytol Histol 2003;25:53-62
21. Koren R, Kugel V, Dekel Y, Weissman Y, Livne PM, Gal R: Human DNA topoisomerase-II alpha expression as a prognostic factor for transitional cell carcinoma of the urinary bladder. Br J Urol Int 2003,91:489-492
22. Potmesil M, Hsiang YH, Liu LF, Bank B, Grossberg H, Kirschenbaum S, Forlenza TJ, Penziner A, Kanganis D, Knowles D, Traganos F, Silber R: Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II. Cancer Res 1988;48:3537-3543
23. Gustafsson U, Einarsson C, Eriksson LC, Gadaleanu V, Sahlin S, Tribukait B. DNA ploidy and S-phase fraction in carcinoma of the gallbladder related to histopathology, number of gallstones and survival. Anal Cell Pathol 2001;23:143-152
24. Koss LG: Tumors of urinary bladder. In Atlas of Tumor Pathology. Second series, vol 11, Washington, DC, Armed Forces Institute of Pathology, 1975
25. Wojcik EM, Miller MC, O'Dowd GJ, Veltri RW: Value of computer-assisted quantitative nuclear grading in differentiation of normal urothelial cells from low and high grade transitional cell carcinoma. Analyt Quant Cytol Histol 1998;20:69-76
26. Sorensen FB, Sasaki M, Fukuzawa S, Yamabe H, Olsen S, Yoshida O: Qualitative and quantitative histopathology in transitional cell carcinomas of the urinary bladder. An international investigation of intra- and interobserver reproducibility. Lab Invest 1994;70:242-254
27. Deverell MH, Whimster WF: A method of image registration for three-dimensional reconstruction of microscopic structures using an IBAS 2000 image analysis system. Pathol Res Pract 1989;185:602-605
28. Blomjous CE, Vos W, Schipper NW, Uyterlinde AM, Baak JP, de Voogt HJ, Meijer CJ: The prognostic significance of selective nuclear morphometry in urinary bladder carcinoma. Hum Pathol 1990;21:409-413